These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 12437079

  • 1. A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT).
    Chikwamba R, Cunnick J, Hathaway D, McMurray J, Mason H, Wang K.
    Transgenic Res; 2002 Oct; 11(5):479-93. PubMed ID: 12437079
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Low-dose exposure and immunogenicity of transgenic maize expressing the Escherichia coli heat-labile toxin B subunit.
    Beyer AJ, Wang K, Umble AN, Wolt JD, Cunnick JE.
    Environ Health Perspect; 2007 Mar; 115(3):354-60. PubMed ID: 17431483
    [Abstract] [Full Text] [Related]

  • 4. Analysis of immune response in young and aged mice vaccinated with corn-derived antigen against Escherichia coli heat-labile enterotoxin.
    Karaman S, Cunnick J, Wang K.
    Mol Biotechnol; 2006 Jan; 32(1):31-42. PubMed ID: 16382180
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
    Byrd W, Boedeker EC.
    Vet Immunol Immunopathol; 2013 Mar 15; 152(1-2):57-67. PubMed ID: 23122616
    [Abstract] [Full Text] [Related]

  • 8. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
    Martin M, Metzger DJ, Michalek SM, Connell TD, Russell MW.
    Infect Immun; 2000 Jan 15; 68(1):281-7. PubMed ID: 10603399
    [Abstract] [Full Text] [Related]

  • 9. Humoral and cellular immune responses in the murine respiratory tract following oral immunization with cholera toxin or Escherichia coli heat-labile enterotoxin.
    Ruedl C, Rieser C, Kofler N, Wick G, Wolf H.
    Vaccine; 1996 Jun 15; 14(8):792-8. PubMed ID: 8817827
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity.
    Dickinson BL, Clements JD.
    Infect Immun; 1995 May 15; 63(5):1617-23. PubMed ID: 7729864
    [Abstract] [Full Text] [Related]

  • 13. Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids.
    Bowman CC, Clements JD.
    Infect Immun; 2001 Mar 15; 69(3):1528-35. PubMed ID: 11179323
    [Abstract] [Full Text] [Related]

  • 14. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J, Bourgeois L, Carlin N, Clements J, Gustafsson B, Lundgren A, Nygren E, Tobias J, Walker R, Svennerholm AM.
    Vaccine; 2013 May 07; 31(20):2457-64. PubMed ID: 23541621
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
    Ruan X, Liu M, Casey TA, Zhang W.
    Clin Vaccine Immunol; 2011 Oct 07; 18(10):1593-9. PubMed ID: 21813665
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant.
    Rask C, Fredriksson M, Lindblad M, Czerkinsky C, Holmgren J.
    APMIS; 2000 Mar 07; 108(3):178-86. PubMed ID: 10752686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.